Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections

INTRODUCTION: The new direct acting antiviral (DAA) therapies are able to effectively treat chronic hepatitis C (CHC). This study elicited the preferences of CHC patients for treatment attributes of new DAAs. METHODS: An online discrete choice experiment survey was designed to collect data from adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Welzel, Tania M., Yang, Min, Sajeev, Gautam, Chen, Yaozhu J., Pinsky, Brett, Bao, Yanjun, Wu, Eric Q., Dieterich, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822851/
https://www.ncbi.nlm.nih.gov/pubmed/31240629
http://dx.doi.org/10.1007/s12325-019-01012-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822851/
https://www.ncbi.nlm.nih.gov/pubmed/31240629
http://dx.doi.org/10.1007/s12325-019-01012-6

Ejemplares similares